Je was op zoek naar: drooling (Engels - Maltees)

drooling
tbeżlieq

increased saliva (drooling)
żieda fl-ammont ta’ bżieq (tlegħib)

bradykinesia drooling dysgeusia parosmia
ebusija fil-moviment bħal ta’ rota tal-ingranaġġ ipertonja bradikinesja tlegħib disgewżja parosmija

in some dogs sneezing, coughing, gagging or drooling may be seen immediately after treatment administration.
immedjatament wara li tiġi amministrata l-mediċina, jista’ jagħti l-każ li xi klieb jibdew jagħtsu, jisgħolu jew jilheġu

there is limited clinical trial evidence on the use of glycopyrronium in the adult population with pathological drooling.
hemm evidenza limitata tal-prova klinika dwar l-użu ta' glikopirronju fil-popolazzjoni adulta bi tlegħib patoloġiku.

in some dogs sneezing, coughing/gagging or drooling may be observed immediately after treatment administration.
f’xi klieb l-għatis, is-sogħla/li jkunu qishom se jirremettu jew it-tlegħib jistgħu jiġu osservati immedjatament wara l-għoti tal-kura.

by blocking the receptors, the medicine is expected to help reduce the amount of saliva produced by the glands and so reduce drooling.
billi timblokka r-riċetturi, il-mediċina hija mistennija li tgħin tnaqqas l-ammont ta' bżieq prodott mill-glandoli u għadaqstant jonqos it-tlegħib.

a brief period of hypersalivation (drooling) may occur if the animal licks the application site immediately after treatment.
perijodu qasir ta’ salivazzjoni eċċessiva (tbeżliq) jista’ jseħħ jekk l-annimal jilgħaq is-sit tal- applikazzjoni immedjatament wara t-trattament.

glycopyrronium is known to have an effect on heart rate and blood pressure at doses used during anaesthesia although clinical trials in children with chronic drooling have not shown this effect.
glikopirronju huwa magħruf li għandu effett fuq ir-rata tat-taħbit tal-qalb u pressjoni tad-demm b'dożi użati waqt il-loppju għalkemm il-provi kliniċi fi tfal bi tlegħib kroniku ma wrewx dan l-effett.

symptomatic treatment of severe sialorrhoea (chronic pathological drooling) in children and adolescents aged 3 years and older with chronic neurological disorders.
il-kura sintomatika ta' sijaloreja severa (tlegħib patoloġiku kroniku) fit-tfal u fl-adolexxenti li għandhom 3 snin u akbar b'disturbi newroloġiċi kroniċi.

other signs of parkinsonism include a slow shuffling walk, a tremor while at rest, increased saliva and/or drooling, and a loss of expression on the face
sinjali oħra ta’ parkinsoniżmu jinkludu mixja mkaxkra, rogħda waqt is-serħan, żieda fir-riq u/jew tbeżlieq, u telf ta’ espressjoni fil-wiċċ.

glycopyrronium bromide is well established in the eu as a treatment for drooling, and published studies show that it is effective in treating severe drooling in children and adolescents with nervous system conditions which can affect their quality of life.
il-bromur tal-glikopirronju huwa stabbilit sew fl-ue bħala kura għat-tlegħib, u studji ppubblikati juru li huwa effikaċi fil-kura ta' tlegħib sever fit-tfal u fl-adolexxenti b'kundizzjonijiet tas-sistema nervuża li jistgħu jaffettwaw il-kwalità tal-ħajja tagħhom.

zeller et al 2012a evaluated the efficacy of glycopyrronium bromide oral solution (1 mg/5 ml) in managing problem drooling associated with cerebral palsy and other neurologic conditions.
zeller et al 2012a evalwaw l-effikaċja tas-soluzzjoni bromur tal-glikopirronju li tittieħed mill-ħalq (1 mg/5 ml) fil-ġestjoni tal-problema tat-tlegħib assoċjata mal-paraliżi ċerebrali u kundizzjonijiet newroloġiċi oħrajn.

upset stomach, indigestion, drooling, more saliva in mouth than normal, vomiting, nausea, diarrhoea, constipation, stomach ache or discomfort, frequent bowel movement
tonku mqalla’, indiġestjoni, aktar riq fil-ħalq minn normal, rimettar, tqalligħ, dijarea, stitikezza, uġigħ jew skumdità fl-istonku, ippurgar frekwenti

parkinsonism includes: increase in saliva secretion or watery mouth, musculoskeletal stiffness, drooling, jerks when bending the limbs, slow, reduced or impaired body movements, no expression on the face, muscle tightness, stiff neck, muscle stiffness, small, shuffling, hurried steps and lack of normal arm movements when walking, persistent blinking in response to tapping of the forehead (an abnormal reflex) • headache, difficulty falling or staying asleep.
parkinsoniżmu jinkludi: żieda fit- tnixxija tal- bżieq jew ħalq dgħumju, ebusija muskolu- skeletrali, tlegħib, ġbid involontarju tal- muskoli meta tgħawweġ l- idejn jew is- saqajn, movimenti tal- ġisem bil- mod, imnaqqsa jew dgħajjfa, l- ebda espressjoni fil- wiċċ, tagħfis fil- muskoli, ebusija fl- għonq, ebusija fil- muskoli, passi żgħar, imkarkrin, bl- għaġġla u nuqqas ta ’ movimenti normali tad- dirgħajn waqt il- mixi, tpetpit ta ’ l - għajnejn persistenti bħala rispons għall- taptip fuq il- ġbin (rifless mhux normali) • uġigħ ta ’ ras, diffikultà biex torqod jew biex tibqa rieqed/ rieqda.